Related Experiment Video
Updated: May 29, 2026

Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
Published on: September 28, 2022
Exploiting mucosal surfaces for the development of mucosal vaccines
1School of Biomedical Sciences, Monash University, Melbourne, Australia. els.meeusen@monash.edu
Mucosal immunity varies across different tissues. Tissue-specific factors guide immune cell development, enabling IgA antibody production and immune responses at various mucosal sites for effective vaccination.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Mucosal immunity protects diverse body surfaces from pathogens.
- Understanding the unique microenvironments of mucosal tissues is crucial for immune response generation.
- The differentiation of B cells into IgA-producing cells is key to mucosal defense.
Purpose of the Study:
- To highlight the diversity of mucosal tissues and their immune microenvironments.
- To explain how tissue-specific factors influence B cell differentiation and IgA production.
- To propose non-oral vaccination strategies targeting accessible mucosal sites.
Main Methods:
- Review of existing literature on mucosal immunity.
- Analysis of tissue-specific factors influencing immune cell differentiation.
- Discussion of antigen delivery and immune response induction at mucosal sites.
Main Results:
- Tissue-specific factors in mucosal tissues and lymph nodes dictate IgA-producing B cell differentiation and migration.
- Mucosal immunity can be induced at any mucosal tissue by antigen delivery, without specialized adjuvants or lymphoid targeting.
- Non-oral vaccination strategies at accessible mucosal sites offer potential for both mucosal and systemic immunization.
Conclusions:
- Mucosal immunity is highly adaptable, with tissue-specific factors playing a critical role.
- Effective mucosal immunization can be achieved through antigen delivery to various mucosal sites.
- Non-oral vaccination approaches utilizing accessible mucosal tissues, supported by large animal models, present promising avenues for future immunization strategies.
More Related Videos
06:02Cationic Nanoemulsion-Encapsulated Retinoic Acid as an Adjuvant to Promote OVA-Specific Systemic and Mucosal Responses
Published on: February 23, 2024
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Related Concept Videos
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Vaccinations
Microorganisms in Medicine and Therapeutics
Vaccines